Brief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Tue 01:22
BRIEF-Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics Oct 27 (Reuters) - Argent BioPharma Ltd RGT.AX:
RGT EXECUTES GLOBAL LICENCE FOR NON-CORE CANNABIS GENETICS
ENTERS 10-YEAR EXCLUSIVE GLOBAL LICENSING AGREEMENT WITH THAI PHYTOMED INTERNATIONAL
Further company coverage: RGT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Executes Global Licence For Non-Core Cannabis Genetics
Brief: Argent Biopharma Files Provisional US Patent On Immune Modulation And Longevity
Australia's Argent BioPharma rises to over 1-month high on new licence agreement
Brief: Argent Biopharma Signs NLC Licence To Expand Antiviral Portfolio
Brief: Argent Biopharma Says FDA-CVM Established Inad File For Cannepil Veterinary Program